Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study

Although Bacillus Calmette Guérin (BCG) remains a mainstay of adjuvant treatment in high-risk, non-muscle-invasive bladder cancer, BCG failure occurs in up to 40% of patients, with radical cystectomy (RC) as the inevitable therapeutic consequence. Current data suggest that PD-L1 immunosuppressive si...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Pichler, Renate, Lindner, Andrea Katharina, Schäfer, Georg, Tulchiner, Gennadi, Staudacher, Nina, Mayr, Martin, Comperat, Eva, Orme, Jacob J., Schachtner, Gert, Thurnher, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7917772/
https://ncbi.nlm.nih.gov/pubmed/33672843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040764
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados